Applied DNA Sciences (GB:0HGQ)
LSE:0HGQ
Holding GB:0HGQ?
Track your performance easily

Applied DNA Sciences (0HGQ) Share Price & Analysis

0 Followers

0HGQ Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Bulls Say, Bears Say

Bulls Say
Financial PerformanceAPDN reported F1Q24 revenue in line with expectations and a narrower GAAP loss per share than estimated.
Operational MilestoneThe company's Linea IVT templates are on track to achieve cGMP status, which will likely expand the customer base.
Strategic PositioningAPDN's strategy to develop into a CDMO positions it well within the biotherapeutics space for RNA-based and DNA-based medicines.
Bears Say
Earnings Miss4Q23 results fall short of expectations excluding Veklury, putting downward pressure on stock prices.
GuidanceThe company has lowered its financial outlook for the upcoming year, which may shake investor confidence.
Revenue DeclineDespite surpassing modest projections, the company's total revenue plummeted by 83% compared to the previous year.
---

Financials

Annual

0HGQ FAQ

What was Applied DNA Sciences’s price range in the past 12 months?
Currently, no data Available
What is Applied DNA Sciences’s market cap?
Currently, no data Available
When is Applied DNA Sciences’s upcoming earnings report date?
Applied DNA Sciences’s upcoming earnings report date is May 09, 2024 which is 163 days ago.
    How were Applied DNA Sciences’s earnings last quarter?
    Applied DNA Sciences released its earnings results on Feb 08, 2024. The company reported -$1.8 earnings per share for the quarter, beating the consensus estimate of -$6.2 by $4.4.
      Is Applied DNA Sciences overvalued?
      According to Wall Street analysts Applied DNA Sciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Applied DNA Sciences pay dividends?
        Applied DNA Sciences does not currently pay dividends.
        What is Applied DNA Sciences’s EPS estimate?
        Applied DNA Sciences’s EPS estimate is -$4.5.
          How many shares outstanding does Applied DNA Sciences have?
          Currently, no data Available
          What happened to Applied DNA Sciences’s price movement after its last earnings report?
          Applied DNA Sciences reported an EPS of -$1.8 in its last earnings report, beating expectations of -$6.2. Following the earnings report the stock price went same N/A.
            Which hedge fund is a major shareholder of Applied DNA Sciences?
            Currently, no hedge funds are holding shares in GB:0HGQ
            ---

            Applied DNA Sciences Stock Smart Score

            Company Description

            Applied DNA Sciences

            Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature, molecular tags, SigNature, T molecular tags, fiberTyping, DNAnet, digitalDNA, SigNify, BackTrac, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.
            ---

            0HGQ Company Deck

            ---

            0HGQ Earnings Call

            Q1 2024
            0:00 / 0:00
            ---

            0HGQ Stock 12 Month Forecast

            Average Price Target

            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
            Similar Stocks
            Company
            Price & Change
            Follow
            Applied DNA Sciences
            Natera
            Genetic Technologies
            Sarepta Therapeutics
            Meiragtx Holdings

            Best Analysts Covering 0HGQ

            1 Year
            Yi ChenH.C. Wainwright
            1 Year Success Rate
            0/16 ratings generated profit
            0%
            1 Year Average Return
            -62.49%
            reiterated a buy rating 8 months ago
            Copying Yi Chen's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -62.49% per trade.
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis